Pages that link to "Q73407423"
Jump to navigation
Jump to search
The following pages link to Essential role of growth hormone in ischemia-induced retinal neovascularization (Q73407423):
Displaying 50 items.
- Microvascular complications and diabetic retinopathy: recent advances and future implications (Q26822476) (← links)
- IGF-I in the clinics: Use in retinopathy of prematurity (Q28070089) (← links)
- Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity (Q28344709) (← links)
- Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2 (Q28368778) (← links)
- Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis (Q30542079) (← links)
- Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor (Q30631779) (← links)
- Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina (Q30903366) (← links)
- Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a (Q30968571) (← links)
- A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial (Q31164826) (← links)
- Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy (Q31918268) (← links)
- Prevention of visual loss in older adults. (Q31952744) (← links)
- Age-related macular degeneration: a review of experimental treatments (Q32004815) (← links)
- Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization (Q33232494) (← links)
- Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS. (Q33360774) (← links)
- Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus (Q33511170) (← links)
- Retinopathy of prematurity: the need for prevention (Q33585466) (← links)
- Retinopathy of prematurity: current concepts in molecular pathogenesis (Q33606227) (← links)
- Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis) (Q33787955) (← links)
- An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration (Q33943213) (← links)
- Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy (Q34005734) (← links)
- Role of connective tissue growth factor in the retinal vasculature during development and ischemia (Q34039271) (← links)
- Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life (Q34090125) (← links)
- Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy (Q34103169) (← links)
- Selective inner retinal dysfunction in growth hormone transgenic mice (Q34117913) (← links)
- The Mechanism of (R,R) ZX-5 on Increasing NO Release (Q34205628) (← links)
- Biological effects of growth hormone and its antagonist (Q34207694) (← links)
- Tenomodulin inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy (Q34314903) (← links)
- Growth hormone receptor antagonists: discovery and potential uses (Q34349411) (← links)
- Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy (Q34463321) (← links)
- Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor (Q34477473) (← links)
- Pathogenesis of retinopathy of prematurity (Q34546104) (← links)
- The pathogenesis of diabetic retinopathy: old concepts and new questions (Q34658478) (← links)
- Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options (Q34704214) (← links)
- Arginase in retinopathy (Q34800913) (← links)
- Targeting Neovascularization in Ischemic Retinopathy: Recent Advances (Q34972210) (← links)
- Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina (Q35088245) (← links)
- Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy (Q35102944) (← links)
- Ophthalmic drug discovery (Q35140846) (← links)
- Functional mapping of somatostatin receptors in the retina: a review (Q35162394) (← links)
- Plasma endothelin-1 concentrations in patients with retinal vein occlusions (Q35304943) (← links)
- Ocular neovascularization: a valuable model system (Q35551128) (← links)
- Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival (Q35553469) (← links)
- Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition (Q35566836) (← links)
- Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy (Q35648554) (← links)
- Fibrosis and diseases of the eye. (Q35649477) (← links)
- Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy (Q35688128) (← links)
- Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy (Q35745360) (← links)
- Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization (Q35745444) (← links)
- Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization (Q35753400) (← links)
- Growth hormone and glucose metabolism: the model of the GH-receptor antagonists. (Q35762332) (← links)